Tocilizumab Stumbles as COVID-19 Treatment, Narrow
Post# of 148112
(Total Views: 703)
Posted On: 10/29/2020 6:27:03 PM
Tocilizumab Stumbles as COVID-19 Treatment, Narrow Role Possible
https://www.medscape.com/viewarticle/939893?s...&faf=1
Tocilizumab (Actemra/RoActemra) was not found to have any clear role as a treatment for COVID-19 in four new studies.
Three randomized controlled trials showed that the drug either had no benefit or only a modest one, contradicting a large retrospective study that had hinted at a more robust effect.
"This is not a blockbuster," said David Cennimo, MD, an infectious disease expert at Rutgers New Jersey Medical School, Newark, New Jersey. "This is not something that's going to revolutionize our treatment of COVID-19."
https://www.medscape.com/viewarticle/939893?s...&faf=1
Tocilizumab (Actemra/RoActemra) was not found to have any clear role as a treatment for COVID-19 in four new studies.
Three randomized controlled trials showed that the drug either had no benefit or only a modest one, contradicting a large retrospective study that had hinted at a more robust effect.
"This is not a blockbuster," said David Cennimo, MD, an infectious disease expert at Rutgers New Jersey Medical School, Newark, New Jersey. "This is not something that's going to revolutionize our treatment of COVID-19."
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼